Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP590517.RAWRPnsK-gZImqy_Ac0-wIgXH9ZbM0Ef1Eud8yJFBh6HE130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590517.RAWRPnsK-gZImqy_Ac0-wIgXH9ZbM0Ef1Eud8yJFBh6HE130_provenance.
• NP743910.RAT9auBYLO3-RozbWsMQMpLxvwWCsCeWJ-0m1WjgazxAM130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743910.RAT9auBYLO3-RozbWsMQMpLxvwWCsCeWJ-0m1WjgazxAM130_provenance.
• assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP108925.RAWPcPahha0oKID90bQMc-3ATbIRZ69KcOZ4pBZx4d24k130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108925.RAWPcPahha0oKID90bQMc-3ATbIRZ69KcOZ4pBZx4d24k130_provenance.
• NP383759.RAQkmlLGlbiEDRVF63odKqJ-wiFS7WASrzTQH8UgMX6qo130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383759.RAQkmlLGlbiEDRVF63odKqJ-wiFS7WASrzTQH8UgMX6qo130_provenance.
• NP384226.RATv_oyKZ8vQUpghBlmo7MGb4QeU5_2PwBpzsnqcsiN-M130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384226.RATv_oyKZ8vQUpghBlmo7MGb4QeU5_2PwBpzsnqcsiN-M130_provenance.
• NP754050.RAxCkFWuYHe6RtJAUB7DtS8tB4UVSAEreMthQ3IWfh1Jg130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754050.RAxCkFWuYHe6RtJAUB7DtS8tB4UVSAEreMthQ3IWfh1Jg130_provenance.
• NP188656.RAfC60T51CRpEA_E2XIt0K0i06VxvixNkBqPRJKkvH2W8130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188656.RAfC60T51CRpEA_E2XIt0K0i06VxvixNkBqPRJKkvH2W8130_provenance.
• NP188657.RAXRcsDehWeo1qcR8WOuwvdbFLPpmz-BD85ap_klwNU4o130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188657.RAXRcsDehWeo1qcR8WOuwvdbFLPpmz-BD85ap_klwNU4o130_provenance.
• NP383748.RAu3AlMgE8E4pmPq6YcpFsJ0_NJmhmw1qwPjFRuxpzPSc130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383748.RAu3AlMgE8E4pmPq6YcpFsJ0_NJmhmw1qwPjFRuxpzPSc130_provenance.
• NP854650.RArppFp9A8cO-Lm-iSzcNPKeAd8tT9-MjRrugQ2shiYNU130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854650.RArppFp9A8cO-Lm-iSzcNPKeAd8tT9-MjRrugQ2shiYNU130_provenance.
• NP140351.RA4qVjY17Z7S0y8EtGWlKv-sCZNdxKURVpovh-OD0ax0g130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140351.RA4qVjY17Z7S0y8EtGWlKv-sCZNdxKURVpovh-OD0ax0g130_provenance.
• NP854648.RA7yH-cGf6g028Jl8fQildsSee_3NHlns5hHPbCPK5xVE130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854648.RA7yH-cGf6g028Jl8fQildsSee_3NHlns5hHPbCPK5xVE130_provenance.
• NP854649.RA9MeBmUkQ4LWPN6qdDTaBo_UXhHCr7NPZ8Gssidiol4I130_assertion description "[To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854649.RA9MeBmUkQ4LWPN6qdDTaBo_UXhHCr7NPZ8Gssidiol4I130_provenance.